Skip to content

Clinical trials

Breast Neoplasms trials in the United Arab Emirates

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: United Arab Emirates Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20123
20171
20201
20211
20221
20232
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Active, not recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Hoffmann-La Roche4
Bristol-Myers Squibb1
European Organisation for Research and Treatment of Cancer - EORTC1
Gulf Medical University1
International Cancer Research Group, United Arab Emirates1
Jinnah Postgraduate Medical Centre1
King Faisal Specialist Hospital & Research Center1
Klinik Hirslanden, Zurich1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms17
Neoplasms2
Blast Crisis1
Breast Diseases1
Burkitt Lymphoma1
Carcinoma, Embryonal1
Carcinoma, Ovarian Epithelial1
Dendritic Cell Sarcoma, Interdigitating1
Endodermal Sinus Tumor1
Fever1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.